The Impact on Therapeutic Effect and Tolerance of Treatment for Patients With Hepatocellular Carcinoma in Transcatheter Arterial Chemoembolization (TACE) of Dexamethasone Application: A Random, Double-blind, Controlled, Clinical Trial.

NCT02987907 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

220

Enrollment

OTHER

Sponsor class

Conditions

HepatoCellular Carcinoma

Interventions

DRUG: Dexamethasone
DRUG: Normal Saline

Sponsor

Sun Yat-sen University